{"data":[{"accessionNo":"0001088875-26-000056","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001714899","issuerName":"Denali Therapeutics Inc.","ticker":"DNLI","cusip":"24823R105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BAILLIE GIFFORD & CO","reportingCik":null,"personType":"IA","sharesOwned":11960230,"percentOfClass":7.5,"filedAt":"2026-08-04"},{"accessionNo":"0001897612-26-000525","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001714899","issuerName":"DENALI THERAPEUTICS INC","ticker":"DNLI","cusip":"24823R105","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":16178963,"percentOfClass":10.2,"filedAt":"2026-07-08"},{"accessionNo":"0001897612-26-000486","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001714899","issuerName":"DENALI THERAPEUTICS INC","ticker":"DNLI","cusip":"24823R105","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":8519192,"percentOfClass":5.4,"filedAt":"2026-05-15"},{"accessionNo":"0000315066-26-001172","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001714899","issuerName":"DENALI THERAPEUTICS INC","ticker":"DNLI","cusip":"24823R105","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":6672999.32,"percentOfClass":4.2,"filedAt":"2026-05-06"},{"accessionNo":"0000315066-26-001172","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001714899","issuerName":"DENALI THERAPEUTICS INC","ticker":"DNLI","cusip":"24823R105","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":6672999.32,"percentOfClass":4.2,"filedAt":"2026-05-06"},{"accessionNo":"0000102909-26-001186","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001714899","issuerName":"Denali Therapeutics Inc","ticker":"DNLI","cusip":"24823R105","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26"},{"accessionNo":"0000315066-25-002719","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001714899","issuerName":"DENALI THERAPEUTICS INC","ticker":"DNLI","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":8536392.34,"percentOfClass":5.8,"filedAt":"2025-11-05"},{"accessionNo":"0000315066-25-002719","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001714899","issuerName":"DENALI THERAPEUTICS INC","ticker":"DNLI","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":8536392.34,"percentOfClass":5.8,"filedAt":"2025-11-05"}],"updatedAt":"2026-10-14T03:56:21.252Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}